Parataxis Holdings, an affiliate of digital asset-focused funding firm Parataxis Capital Administration, is about to launch a Bitcoin-native treasury platform within the South Korean public market.
The agency introduced on Friday it had entered a definitive settlement to take a position 25 billion South Korean gained ($18.5 million) into Bridge Biotherapeutics, a publicly traded biotech firm.
Following the acquisition, Parataxis will take a controlling curiosity within the agency, which shall be renamed Parataxis Korea and repurposed as a treasury automobile for institutional Bitcoin (BTC) publicity.
“Impressed by the rising curiosity in BTC treasury methods seen in firms like Technique within the US and Metaplanet in Japan, we consider institutional curiosity on this house is rising globally,” mentioned Andrew Kim, Accomplice at Parataxis Capital. “We see South Korea as an necessary market within the evolution of BTC adoption.”
Kim added that the agency’s intent is to assist institutional entry to Bitcoin whereas emphasizing sound company governance and disciplined capital administration.
At present, Bitcoin exchange-traded funds (ETFs) and institutional crypto investments are banned in South Korea.
Nevertheless, the nation’s Monetary Providers Fee (SFC) has allowed 3,500 companies {and professional} traders to open “real-name” accounts within the first half of 2025 as a part of a pilot program aiming to progressively allow institutional digital asset investments.
Associated: ‘Apple can buy Bitcoin,’ Saylor says, as share buyback disappoints
Parataxis’ new platform was introduced over every week after the New York-headquartered agency introduced plans to go public by way of a $200 million particular acquisition firm, Cointelegraph reported on June 10.
The Parataxis announcement comes amid a wave of company Bitcoin adoption. Greater than 237 public firms now maintain Bitcoin on their stability sheets, up from 124 corporations simply weeks earlier, representing roughly 3.96% of the full BTC provide, in line with BitcoinTreasuries.NET.
Associated: Nasdaq-listed Mercurity Fintech to boost $800M for Bitcoin treasury
Inventory rallies comply with treasury bulletins
Bridge Biotherapeutics’ inventory rose greater than 20% on the every day chart following information of the acquisition, in line with TradingView information. Nevertheless, the biotech agency’s inventory stays down 74% year-to-date and over 90% from its five-year excessive.
Based in 2015 and listed on the Korean Securities Sellers Automated Quotations in 2019, Bridge Biotherapeutics develops therapeutics for the remedy of ulcerative colitis, fibrotic ailments and most cancers.
Earlier at present, London-based synthetic intelligence options agency Pri0r1ty Intelligence Group introduced plans to undertake Bitcoin as a reserve asset and fee answer with out disclosing a direct Bitcoin funding.
Following the announcement, the agency’s inventory value rose over 84% on the every day chart, reversing its one-year downtrend of 32%, Google Finance information exhibits.
Not all firms are benefiting equally. GameStop shares fell greater than 22% after the online game retailer elevated its convertible notice providing to $2.25 billion, which some analysts interpreted as a sign of additional crypto-related investments.
Journal: Arthur Hayes $1M Bitcoin tip, altcoins ‘highly effective rally’ looms: Hodler’s Digest, Could 11 – 17